sapogenins and Peritonitis

sapogenins has been researched along with Peritonitis* in 1 studies

Other Studies

1 other study(ies) available for sapogenins and Peritonitis

ArticleYear
Ginsenoside metabolite 20(S)-protopanaxatriol from Panax ginseng attenuates inflammation-mediated NLRP3 inflammasome activation.
    Journal of ethnopharmacology, 2020, Apr-06, Volume: 251

    Panax ginseng C.A. Meyer (Araliaceae), has been used in traditional medicine for preventive and therapeutic purposes in Asian countries. One of the active ginsenoside metabolites, 20(S)-Protopanaxatriol (PPT), has been associated with diverse pharmacological effects, including anti-inflammatory properties.. Although the capacity of PPT as an anti-inflammatory agent has been studied, this study aimed to explore the intrinsic mechanism of PPT in regulating inflammasome activation-mediated inflammatory responses in experimental models.. Lipopolysaccharide (LPS)-primed peritoneal macrophages in vitro was used to study the role of PPT on inflammasome activation. LPS-induced septic shock and monosodium urate (MSU)-induced murine peritonitis models were employed for in vivo evaluations.. PPT attenuated NLRP3 inflammasome activation and also reduced ASC oligomerization, leading to attenuation of interleukin (IL)-1β secretion. Further, PPT inhibited IL-1β secretion in both LPS-induced septic shock and MSU-induced mouse peritonitis models.. This study revealed that ginsenoside metabolite PPT, inhibits inflammation-mediated inflammasome activation and supported the traditional use of ginseng in treating various inflammatory disorders.

    Topics: Animals; Anti-Inflammatory Agents; Ginsenosides; Inflammasomes; Interleukin-1beta; Lipopolysaccharides; Macrophages, Peritoneal; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Panax; Peritonitis; Sapogenins; Shock, Septic; Uric Acid

2020